AEW Double or Nothing 2026 Match Card Highlights and Streaming Details Announced Novartis Raises FullYear Guidance on Strong Operational Momentum Anthropic and Microsoft in Talks for AI Chip Deal Amid 5 Billion Investment Wall Street Gains Amid Iran Peace Talks Estee Lauder and Zoom Lead Advancers Adani Power Overtakes Infosys as 11th Most Valuable Indian Firm Amid 66 YTD Surge Gold and Silver Poised for Next Upswing 360 ONE Assets Rahul Khetawat Outlines Tactical Allocation Strategy Flutter Entertainment Q1 2026 Earnings EPS Slightly Misses Estimates Amidst Strong Operating Trends Capital Bancorp Inc CBNK Q1 2026 Earnings EPS Misses Estimates Amid Modest Stock Decline TLF Q1 2026 Earnings Modest Profitability Amid Quiet Quarter Mirion Technologies MIR Q1 2026 Earnings EPS Beat Drives Positive Stock Momentum STRRP Q1 2026 Earnings Preferred Stock Reports Sharp EPS Miss Yet Shares Gain Atlanta Braves Holdings Inc Series A BATRA Q1 2026 Earnings NarrowerThanExpected Loss Highlights Cost Discipline Amid OffSeason UDR Inc Shows Modest Gains as REIT Sector Finds Footing Eaton Vance Municipal Income Trust EOT Advances 217 as TaxExempt Yield Appeal Drives Demand Network1 Technologies NTIP Edges Lower as Stock Approaches Key Support Zone Launch Two Acquisition Corp LPBB Holds Steady Near Upper Trading Range Starwood Property Trust STWD Hovers Near Support as Slight Decline Continues US Retail Sales Growth Slows as Consumer Sentiment Dips on Labor Market Concerns BUSE Q1 2026 Earnings Strong EPS Beat Drives Optimism Banzai International Warrant BNZIW Shows Modest Gains Amid LowPriced Trading BitMine Immersion Technologies BMNR Under Pressure as Shares Slide 372 RenaissanceRe RNR Holds Near Support After Modest Decline Reinsurance Sector in Focus FMY Sees Modest Uptick Amid Stabilizing Mortgage Income Fund Performance Tucows Inc TCX Holds Steady Near Support as Trading Volume Remains Subdued Altisource Portfolio Solutions ASPS Edges Lower as Stock Tests Key Support Zone PS International Group PSIG Surges 183 as Stock Tests Key Resistance Level at 82 Kymera Therapeutics KYMR Retreats 148 as Stock Tests Key Support Level